The federal government is currently on track to implement regulatory changes to the Patented Medicines Prices Review Board on July 1. These changes will negatively impact the lives of Canadians who depend on medications.
By Schneider Electric’s Secure Power Division - Canada
Enter your email address to
register a free account.